3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Tight belts not a factor in esophageal cancer rise

CancerNov 07, 06

A new study from Sweden debunks the theory that men’s switch from suspenders to belts is behind the sharp rise in throat cancer seen over the past several decades.

While known risk factors for esophageal cancer include male gender, being overweight, and having gastric acid reflux, Drs. Jesper Lagergren and Catarina Jansson of the Karolinska Institute in Stockholm note, the reasons remain unclear why the disease is becoming more common.

In 2002, an Italian research team proposed that the general shift from suspenders to belts could be a factor in the rise in esophageal cancer, especially among overweight men. The theory is plausible, Lagergren and Jansson point out, given that tight belts can squeeze the stomach and increase acid reflux into the esophagus, which in turn increases esophageal cancer risk.

To investigate, they surveyed 618 patients with different types of esophageal cancer and stomach cancer, and 820 healthy controls. All were asked how frequently they had used “a belt or corset or other garment that was tightened around your waist with force” for more than three hours, 20 years previously.

About 10% of the study participants reported daily use of tight belts, but the researchers found no association between frequency of tight belt use and esophageal cancer.

This nationwide, population-based study “provides evidence against a link between the use of tight belts and the risk of esophageal or cardia adenocarcinoma,” the researchers write. “Further studies are urgently needed to find an explanation for the alarmingly increasing incidence of esophageal adenocarcinoma.”

SOURCE: International Journal of Cancer, November 15, 2006.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site